Advertisement

Neuro-oncologic Emergencies

  • Jessica Clymer
  • Peter E. ManleyEmail author
Chapter

Abstract

Brain tumors are the most common solid tumor in children, and unfortunately, they carry the highest mortality rate of any of the pediatric cancers. The tumor itself can pose significant risk to the patient due to local effects on the central nervous system which can be life threatening if not addressed quickly. In addition, treatment can also pose significant risks to the patient as damage to the brain has a much slower recovery than any other organ in the body. This can have long-term ramifications to the patient’s overall functionality for his or her lifetime.

This chapter will touch on key risks that a pediatric brain tumor patient can have and if quickly addressed can make a significant positive lifelong impact.

Keywords

Brain tumor Pediatric Seizure Hydrocephalus Toxicity Brain injury Encephalopathy Endocrine dysfunction 

References

  1. 1.
    Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro-Oncology. 2016;18(suppl_5):v1–v75.CrossRefGoogle Scholar
  2. 2.
    Ostrom QT, et al. Alex’s lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-Oncology. 2015;16(Suppl 10):x1–x36.CrossRefGoogle Scholar
  3. 3.
    de Blank PM, et al. Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009. Cancer Med. 2015;4(4):608–19.CrossRefGoogle Scholar
  4. 4.
    Smith ER, Madsen JR. Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure. Semin Pediatr Neurol. 2004;11(2):89–104.CrossRefGoogle Scholar
  5. 5.
    Lin AL, Avila EK. Neurologic emergencies in the patients with cancer. J Intensive Care Med. 2017;32(2):99–115.CrossRefGoogle Scholar
  6. 6.
    Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43(9):1678–83.CrossRefGoogle Scholar
  7. 7.
    Stocchetti N, et al. Hyperventilation in head injury: a review. Chest. 2005;127(5):1812–27.CrossRefGoogle Scholar
  8. 8.
    Damek DM. Cerebral edema, altered mental status, seizures, acute stroke, leptomeningeal metastases, and paraneoplastic syndrome. Emerg Med Clin North Am. 2009;27(2):209–29.CrossRefGoogle Scholar
  9. 9.
    Pater K, Puskulluoglu M, Zygulska AL. Oncological emergencies: increased intracranial pressure in solid tumours’ metastatic brain disease. Przegl Lek. 2014;71(2):91–4.PubMedGoogle Scholar
  10. 10.
    Glantz MJ, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;54(10):1886–93.CrossRefGoogle Scholar
  11. 11.
    Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54(Suppl 9):12–7.CrossRefGoogle Scholar
  12. 12.
    Ruda R, et al. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology. 2012;14(Suppl 4):iv55–64.CrossRefGoogle Scholar
  13. 13.
    Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014;19(7):751–9.CrossRefGoogle Scholar
  14. 14.
    Cavaliere R, Farace E, Schiff D. Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol. 2006;63(12):1746–9.CrossRefGoogle Scholar
  15. 15.
    Brophy GM, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.CrossRefGoogle Scholar
  16. 16.
    Rossetti AO, et al. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-Oncology. 2014;16(4):584–8.CrossRefGoogle Scholar
  17. 17.
    Pollono D, et al. Spinal cord compression: a review of 70 pediatric patients. Pediatr Hematol Oncol. 2003;20(6):457–66.CrossRefGoogle Scholar
  18. 18.
    Lewis DW, et al. Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. Pediatrics. 1986;78(3):438–43.PubMedGoogle Scholar
  19. 19.
    Patchell RA, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–8.CrossRefGoogle Scholar
  20. 20.
    Sylvester RK, Fisher AJ, Lobell M. Cytarabine-induced cerebellar syndrome: case report and literature review. Drug Intell Clin Pharm. 1987;21(2):177–80.PubMedGoogle Scholar
  21. 21.
    Herzig RH, et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol. 1987;5(6):927–32.CrossRefGoogle Scholar
  22. 22.
    Kwong YL, Yeung DY, Chan JC. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol. 2009;88(3):193–201.CrossRefGoogle Scholar
  23. 23.
    Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017;8(3):33–48.CrossRefGoogle Scholar
  24. 24.
    Fenske W, Allolio B. Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab. 2012;97(10):3426–37.CrossRefGoogle Scholar
  25. 25.
    Loh JA, Verbalis JG. Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab. 2007;3(6):489–94.CrossRefGoogle Scholar
  26. 26.
    Mortini P, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011;114(5):1350–9.CrossRefGoogle Scholar
  27. 27.
    Williams C, et al. Hyponatremia with intracranial malignant tumor resection in children. J Neurosurg Pediatr. 2012;9(5):524–9.CrossRefGoogle Scholar
  28. 28.
    Williams CN, et al. The incidence of postoperative hyponatremia and associated neurological sequelae in children with intracranial neoplasms. J Neurosurg Pediatr. 2014;13(3):283–90.CrossRefGoogle Scholar
  29. 29.
    Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21(2):339–52.CrossRefGoogle Scholar
  30. 30.
    Hardesty DA, Kilbaugh TJ, Storm PB. Cerebral salt wasting syndrome in post-operative pediatric brain tumor patients. Neurocrit Care. 2012;17(3):382–7.CrossRefGoogle Scholar
  31. 31.
    Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581–9.CrossRefGoogle Scholar
  32. 32.
    Lo AC, et al. Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2014;88(5):1011–8.CrossRefGoogle Scholar
  33. 33.
    Rogers LR, et al. Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis. J Neuro-Oncol. 2011;101(1):25–32.CrossRefGoogle Scholar
  34. 34.
    Drezner N, et al. Treatment of pediatric cerebral radiation necrosis: a systematic review. J Neuro-Oncol. 2016;130(1):141–8.CrossRefGoogle Scholar
  35. 35.
    Sundgren PC, Cao Y. Brain irradiation: effects on normal brain parenchyma and radiation injury. Neuroimaging Clin N Am. 2009;19(4):657–68.CrossRefGoogle Scholar
  36. 36.
    Greene-Schloesser D, et al. Radiation-induced brain injury: a review. Front Oncol. 2012;2:73.CrossRefGoogle Scholar
  37. 37.
    Sadraei NH, et al. Treatment of cerebral radiation necrosis with bevacizumab: the cleveland clinic experience. Am J Clin Oncol. 2015;38(3):304–10.CrossRefGoogle Scholar
  38. 38.
    Delishaj D, et al. Bevacizumab for the treatment of radiation-induced cerebral necrosis: a systematic review of the literature. J Clin Med Res. 2017;9(4):273–80.CrossRefGoogle Scholar
  39. 39.
    Pruitt AA. Central nervous system infections in cancer patients. Semin Neurol. 2004;24(4):435–52.CrossRefGoogle Scholar
  40. 40.
    Pruitt AA. CNS infections in patients with cancer. Continuum (Minneap Minn). 2012;18(2):384–405.Google Scholar
  41. 41.
    Baldwin KJ, Zivkovic SA, Lieberman FS. Neurologic emergencies in patients who have cancer: diagnosis and management. Neurol Clin. 2012;30(1):101–28. viiiCrossRefGoogle Scholar

Copyright information

© Springer International Publishing 2019

Authors and Affiliations

  1. 1.Pediatric Neuro-oncologyDana-Farber/Boston Children’s Cancer and Blood Disorders CenterBostonUSA

Personalised recommendations